Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.02. | BrightSpring Health Services, Inc. (BTSG): Among the Health Information Services Stocks Outpacing the Market in 2025 | 3 | Insider Monkey | ||
02.02. | Why BrightSpring Health Services, Inc. (BTSG) Is Among the Best Booming Stocks to Invest in Now? | 2 | Insider Monkey | ||
29.01. | The Analyst Verdict: BrightSpring Health In The Eyes Of 7 Experts | 2 | Benzinga.com | ||
27.01. | Brightspring Health stock hits all-time high at $81.03 | 2 | Investing.com | ||
BRIGHTSPRING HEALTH SERVICES Aktie jetzt für 0€ handeln | |||||
27.01. | Brightspring Health stock soars to all-time high of $22.97 | 1 | Investing.com | ||
21.01. | BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities | 3 | Benzinga.com | ||
21.01. | BrightSpring Health stock rises on divestiture plan | 1 | Investing.com | ||
21.01. | BrightSpring Health-Aktie steigt nach Ankündigung von Veräußerungsplan | 2 | Investing.com Deutsch | ||
21.01. | BrightSpring Health Services, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
21.01. | BrightSpring divests community living business for $835M; raises FY24 revenue outlook | 2 | Seeking Alpha | ||
21.01. | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | 148 | GlobeNewswire (Europe) | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
14.01. | BrightSpring Health Services, Inc. TANGIBLE EQUITY UNIT goes ex dividend tomorrow | 4 | Seeking Alpha | ||
11.12.24 | BrightSpring Health Services, Inc. Announced Refinancing of Term Loan B | 1 | GlobeNewswire (USA) | ||
11.12.24 | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
26.11.24 | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Onco360 Has Been Selected as a Partner for Several New Drugs | 1 | GlobeNewswire (USA) | ||
15.11.24 | BrightSpring Health Services, Inc. - 8-K, Current Report | - | SEC Filings | ||
06.11.24 | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi | 1 | GlobeNewswire (USA) | ||
04.11.24 | KeyBanc maintains Sector Weight on BrightSpring Health shares | 1 | Investing.com | ||
01.11.24 | BrightSpring Health Services, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
01.11.24 | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | 448 | GlobeNewswire (Europe) | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
MEDTRONIC | 85,75 | -0,30 % | ROUNDUP: Medtronic Reiterated FY25 Outlook | WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Tuesday, medical devices maker Medtronic plc. (MDT) reiterated its adjusted earnings and organic revenue growth... ► Artikel lesen | |
INTUITIVE SURGICAL | 567,20 | +0,27 % | Stock-Split Watch: Is Intuitive Surgical Next? | ||
THERMO FISHER | 509,40 | +0,06 % | Thermo Fisher CDR (CAD Hedged): Thermo Fisher CDR (CAD Hedged) estimates distribution | ||
ROKU | 85,20 | +0,27 % | Streaming-Revolution?: Roku-Rallye: Analysten heben Kursziele drastisch an! | © Foto: Pavlo Gonchar - picture allianceDie Kursziele von Roku wurden angehoben, da Analysten großes Wachstumspotenzial sehen - steckt hier die nächste große Investmentchance?Die Aktie von Roku verzeichnete... ► Artikel lesen | |
DEXCOM | 84,98 | +0,13 % | DexCom Inc. Q4 Income Falls | WASHINGTON (dpa-AFX) - DexCom Inc. (DXCM) released a profit for fourth quarter that decreased from last yearThe company's bottom line totaled $151.7 million, or $0.38 per share. This compares... ► Artikel lesen | |
RESMED | 220,80 | -0,27 % | 6,300 Shares in ResMed Inc. (NYSE:RMD) Acquired by Hussman Strategic Advisors Inc. | ||
ATOSSA THERAPEUTICS | 0,790 | -7,49 % | Atossa Therapeutics, Inc. (NASDAQ:ATOS) Sees Significant Growth in Short Interest | ||
GE HEALTHCARE TECHNOLOGIES | 86,95 | -0,20 % | Enlitic and GE HealthCare partner to revolutionise AI-driven medical imaging migration | ||
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
ORGANON | 14,695 | -0,74 % | Organon & Co. (NYSE:OGN) Shares Down 5.9% Following Weak Earnings | ||
QUIDELORTHO | 38,800 | 0,00 % | QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in-vitro diagnostic technologies designed for point-of-care... ► Artikel lesen | |
CENTENE | 55,41 | +0,45 % | CENTENE CORP - 10-K, Annual Report | ||
VERU | 0,542 | -1,63 % | Veru Inc. Direktor Michael Rankowitz erwirbt Stammaktien im Wert von 84.350 US-Dollar | ||
TEMPEST THERAPEUTICS | 0,865 | +4,92 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
NANO-X IMAGING | 6,315 | -1,33 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen |